Alphora Research Inc. provides API (Active Pharmaceutical Ingredient) technology development services for the scale-up of complex small molecules for Pharmaceutical and Biotechnology companies.
Our core focus is process chemistry and analytical services for early stage development of pre-clinical and clinical candidates, where speed and quality are paramount.
As well, Alphora provides process chemistry expertise to later stage development programs where process economics, specifications, impurity profile characterization, regulatory strategies and supply chain management considerations are important.
This focus provides Alphora's Client's with a complete and comprehensive API technology platform to meet the developmental requirements from pre-clinical through phase III and for the successful technology transfer to manufacturing locations throughout the world.
.... providing the Right Development at the Right Time
Alphora's talented chemists and staff provide phase appropriate solutions with the Client's immediate needs and milestones in mind, as well the long term commercial considerations.
Founded in 2003 by Dr. Jan Oudenes, Alphora is an FDA inspected and approved CRO located in Mississauga, Ontario, Canada and centered within the North American Pharmaceutical and Biotechnology industry. Alphora is staffed by 90 employees, including 18 Ph.D. chemists, 60 scientists as well as engineers and support staff.